DrugDashboards

Enoxaparin Sodium

Enoxaparin Sodium · ENOXAPARIN SODIUM 40 mg/.4mL · Injection, Solution · Subcutaneous · Hepalink USA Inc.

NDC 81952-0124-24 · 10 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 15% over the past year, to $8.13 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.3% of the time — roughly 2× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$8.13per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicare Part B pays (ASP+6%)$0.5360per billing unit (10 MG)HCPCS J1650 · Jul 1, 2026
  • Part D plans paid (avg)$12.25per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$5.00$10.00$15.00May 2023Sep 2026$8.13
41 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$84.84
Reported to Texas DSHS · 2026 annual filing · Hepalink Usa

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MG
$0.536
HCPCS J1650 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$1.5M
22,149 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

15Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 4 active manufacturers+5
  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.3%chance of a new FDA shortage posting for enoxaparin sodium (injectable) in the next 90 days

sterile injectable · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $149.18 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA205660
TE code
AP
Approval date
Mar 15, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Enoxaparin Sodium (Injection, Solution)

LabelerStrengthFirst seenLast seen
Hepalink USA Inc.ENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.ENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.ENOXAPARIN SODIUM 60 mg/.6mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.ENOXAPARIN SODIUM 30 mg/.3mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.ENOXAPARIN SODIUM 120 mg/.8mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.ENOXAPARIN SODIUM 80 mg/.8mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.ENOXAPARIN SODIUM 40 mg/.4mLJul 15, 2026Sep 2, 2026
Italfarmaco SpAENOXAPARIN SODIUM 30 mg/.3mLJul 15, 2026Sep 2, 2026
Italfarmaco SpAENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
Italfarmaco SpAENOXAPARIN SODIUM 120 mg/.8mLJul 15, 2026Sep 2, 2026
Italfarmaco SpAENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 2, 2026
Italfarmaco SpAENOXAPARIN SODIUM 40 mg/.4mLJul 15, 2026Sep 2, 2026
Italfarmaco SpAENOXAPARIN SODIUM 60 mg/.6mLJul 15, 2026Sep 2, 2026
Italfarmaco SpAENOXAPARIN SODIUM 80 mg/.8mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCENOXAPARIN SODIUM 120 mg/.8mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCENOXAPARIN SODIUM 40 mg/.4mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCENOXAPARIN SODIUM 80 mg/.8mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCENOXAPARIN SODIUM 60 mg/.6mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCENOXAPARIN SODIUM 30 mg/.3mLJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ENOXAPARIN SODIUM 120 mg/.8mLJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ENOXAPARIN SODIUM 30 mg/.3mLJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ENOXAPARIN SODIUM 80 mg/.8mLJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ENOXAPARIN SODIUM 60 mg/.6mLJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ENOXAPARIN SODIUM 40 mg/.4mLJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Enoxaparin Sodium — NDC 81952-0124-24," retrieved September 3, 2026, https://drugdashboards.com/drug/81952012424.

Free to cite with attribution — see how the data is put together.